Willing Hearts, Helpful Hands
Are you a caregiver to a person with Alzheimer’s disease or another dementia? Would you like to have a better understanding of dementia and the disease process? We can help! The Willing Hearts, Helpful Hands program is now offering a family training program, with an approved curriculum from the Alzheimer’s Association called Cares®, Dementia Care for Families.
This program is designed to give caregivers education about their loved ones’ disease and offer helpful tips and strategies to make their difficult job as caregiver a little bit easier.
The CARES® training program will help you to understand memory loss, how to live with dementia and using the Cares® approach. The Cares® approach teaches caregivers how to connect with their loved one, assess behaviors, respond appropriately, evaluate what works and to share with others. Upon completion of the program, families will have a better understanding of what dementia is and what their loved one may be experiencing. Caregivers will also gain a sense of comfort and confidence when caring for their loved one.
Training sessions are offered throughout Nassau and Suffolk Counties at convenient times and locations.
Do you have difficulty leaving your loved one and want to attend one of our trainings? We can help organize care for your family member so that you can attend this valuable training. We also have a limited number of training opportunities available for caregivers to access online from the comfort of their home.
Our staff have completed the Dementia Cares training and are able to answer any questions you may have.
Opportunities to Participate in Clinical Research Study
While Alzheimer’s disease can be devastating to patients, families, and their caregivers, clinical trials are looking at new ways to fight this disease and are great opportunities to participate and make a difference.
Hope Through Research
The Rethink-ALZ trial is now open to qualifying participants. The trials last for 52 weeks. If you enroll into this trial, you will receive either the oral study drug or placebo twice a day. A placebo looks like the study drug but has no impact on the person taking it. There is no cost to the patient to participate in the Rethink-ALZ trial or for any of the study-related procedures. No hospitalization is required. If you or a loved one are interested in participating in one of these studies, the following criteria must be met:
- Be ages 50 to 87 years old.
- Be diagnosed with, or have a suspected clinical diagnosis of, Alzheimer’s disease.
- Have a gradual change in memory for six months or more.
- Have a family member or loved one who can be available as a study partner during the entire study.
- Be fully vaccinated for COVID-19 or have had a previous COVID-19 infection.
Other criteria will apply.
Paving a Better Future
Agitation associated with Alzheimer’s dementia can be difficult to manage and can be very challenging for patients and their loved ones. The ASPECTTM clinical research study is evaluating an investigational drug for agitation associated with Alzheimer’s dementia and participants are needed. Participants will not have to pay for the study drug (the investigational drug or placebo), study supplies, study visits, or study tests. Health insurance is not required. To be eligible, participants must:
- Be between the ages of 50 and 90.
- Have a diagnosis of probable Alzheimer’s dementia.
- Have moderate-to-severe agitation that interferes with their daily life.
- Have a reliable caregiver who is able to comply with all study procedures
.Other criteria will apply.